The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on photo-dynamic therapy for early oesophageal cancer in December 2006. In accordance with the Interventional Procedures Programme Process Guide, guidance on procedures with special arrangements are reviewed 3 years after publication and the procedure is reassessed if important new evidence is available.
The guidance was considered for reassessment in December 2009 and it was concluded that NICE will not be updating this guidance at this stage. However, if you believe there is new evidence which should warrant a review of our guidance, please contact us via the email address below.
Oesophageal cancer usually originates in the lining of the oesophagus and can develop in the upper, middle, or lower section of the organ. Photodynamic therapy uses light to kill cancer cells. The patients takes a drug that makes cancerous cells sensitive to light. Then the doctor shines a very bright light onto the oesophagous which activates the drug and kills the cells.
G14.7 Fibreoptic endoscopic photodynamic therapy of lesion of oesophagus
In addition an ICD-10 code from category C15. - Malignant neoplasm of oesophagus or C78.8 Secondary malignant neoplasm of other and unspecified digestive organs is assigned.
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.